Tellgen Corporation

Shenzhen Stock Exchange 300642.SZ

Tellgen Corporation Gross Profit for the year ending December 31, 2023: USD 49.89 M

Tellgen Corporation Gross Profit is USD 49.89 M for the year ending December 31, 2023, a -15.69% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Tellgen Corporation Gross Profit for the year ending December 31, 2022 was USD 59.18 M, a -14.07% change year over year.
  • Tellgen Corporation Gross Profit for the year ending December 31, 2021 was USD 68.87 M, a 38.30% change year over year.
  • Tellgen Corporation Gross Profit for the year ending December 31, 2020 was USD 49.80 M, a -0.02% change year over year.
  • Tellgen Corporation Gross Profit for the year ending December 31, 2019 was USD 49.81 M, a 19.71% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
SV Wall Street
Shenzhen Stock Exchange: 300642.SZ

Tellgen Corporation

CEO Mr. Jian Er Yao
IPO Date April 21, 2017
Location China
Headquarters Building 1
Employees 574
Sector Healthcare
Industries
Biotechnology 3D Printing Cleaning Supplies Cosmetics Glass Personal Care Pharmaceuticals Vaccines
Description

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email